Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam plus low-dose propofol for anesthesia induction and maintenance in elderly spinal surgery
ChiCTR2400079846Phase 4Not yet recruiting
- Sponsor
- The First College of Clinical Medical Science, China Three Gorges University
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol (4 arms), sponsored by The First College of Clinical Medical Science, China Three Gorges University. Primary endpoints: 95% effective dose of remimazolam for successful intubation sedation, Time to consciousness and 1 more. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2400079846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079846.